S85482 |
SCH 527123 |
源叶(MedMol) | 99% |
- 提示:详情请下载说明书。
- 产品描述: Navarixin (SCH-527123, MK-7123, PS-291822)是有效的、具有口服生物利用度的CXCR2/CXCR1拮抗剂,IC50分别为2.6 nM和36 nM
- 靶点: CXCR2(Cell-free assay):2.6 nM; CXCR1(Cell-free assay):36 nM;CXCR
- 体外研究:
Navarixin (SCH-527123, MK-7123, PS-291822) is a potent, orally bioavailable CXCR2/CXCR1 antagonist with IC50 values of 2.6 nM and 36 nM, respectively.
- 体内研究:
SCH52712, a novel, orally active CXCR1/2 receptor antagonist, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
- 动物实验: Animal Models: Male BALB/c mice Dosages: 3 mg/kg Administration: o.g.
- 参考文献:
1. Dwyer MP, et al. Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. J Med Chem. 2006, 49(26):7603-6. 2. Chapman RW, et al. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther. 2007 Aug;322(2):486-93.
- 溶解性: Soluble in DMSO、Ethanol
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.516 ml 12.581 ml 25.162 ml 5 mM 0.503 ml 2.516 ml 5.032 ml 10 mM 0.252 ml 1.258 ml 2.516 ml 50 mM 0.05 ml 0.252 ml 0.503 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)